Calystegine A3 (Nortropane Alkaloid · Food Constituent · Informational)

Compound	Calystegine A3
Chemical class	Alkaloid — Tropane (polyhydroxylated nortropane; sugar-mimic)
CAS	139392-33-9
Primary source	Solanum tuberosum (potato), Solanum melongena (eggplant), tomato, sweet potato
Key applications	Food-occurring constituent; glycosidase interaction; analytical/toxicological reference
Claim strength	Emerging
Typical form	Naturally occurring food constituent; not a supplement ingredient
Buy from Herbuno	Informational reference — see HerbIQ Compound Index →

Name origin: The calystegines are named for Calystegia sepium (hedge bindweed, Convolvulaceae), the plant from which they were first reported in 1988. Calystegine A3 is one of the trihydroxylated members of this polyhydroxylated nortropane family — nortropane because the bridging nitrogen is secondary rather than N-methylated, distinguishing the calystegines from the classical tropane alkaloids such as atropine and scopolamine. Their densely hydroxylated bicyclic cores make them structural mimics of sugars. Traditional use: Calystegine A3 has no traditional medicinal identity whatsoever, and this is precisely what makes it interesting: it is not a medicinal alkaloid but a constituent of everyday food. It has been found in more than 70 varieties of potato and across most genera of the Solanaceae, as well as in edible species such as Solanum melongena (eggplant) and Ipomoea batatas (sweet potato), which means ordinary diets deliver measurable quantities. Research trajectory: Calystegines derive from the tropane alkaloid biosynthetic pathway and share its first enzymatic steps, and their formation in potato has been traced to putrescine N-methyltransferase activity in sprouting tubers, notwithstanding that potato produces neither nicotine nor the medicinal tropanes Stenzel 2006. Interest in them focuses on two areas: they are glycosidase-interacting sugar mimics with possible therapeutic relevance, and they are food and feed constituents with possible toxic effects. On the first, careful study of human intestinal enzymes found that calystegine A3 showed only low in vitro inhibition of maltase and sucrase, while calystegine B2 inhibited sucrase more substantially, and neither was transported by Caco-2 cells, indicating low systemic availability Hamid 2013. Commercial source: Calystegine A3 is a food-occurring compound and analytical reference, not an ingredient; Herbuno does not offer it.

---

Evidence for Calystegine A3 Applications

Weak glycosidase inhibition: Despite the calystegines' class reputation as glycosidase inhibitors, calystegine A3 specifically showed low in vitro inhibition of the human intestinal alpha-glucosidases maltase and sucrase, with calystegine B2 the more active of the two compounds tested against sucrase; in silico docking confirmed both bind the enzyme active sites, but binding did not translate into strong functional inhibition for A3 Hamid 2013. This is an important corrective to the assumption that all calystegines are potent enzyme inhibitors. Claim strength: Emerging.

Low systemic availability: Neither calystegine A3 nor B2 was transported across Caco-2 cell monolayers, indicating low intestinal absorption and therefore limited systemic exposure from dietary intake Hamid 2013. This matters both for any hypothetical therapeutic interest and for toxicological risk assessment. Claim strength: Emerging.

Biosynthetic origin: Calystegines are formed via the tropane alkaloid biosynthetic pathway and share its first enzymatic steps; potato contains putrescine N-methyltransferase activity and N-methylputrescine in sprouting tubers, confirming that the pathway operates in this calystegine-forming plant even though potato makes neither nicotine nor hyoscyamine Stenzel 2006. Claim strength: Emerging.

Food occurrence and stability: Calystegines occur across most genera of the Solanaceae and in the Convolvulaceae, have been found in over 70 potato varieties, and are stable enough to survive cooking and to be detected in processed potato products; cold storage at around 5 degrees Celsius increases the proportion of calystegine A3 specifically. Claim strength: Emerging.

Toxicological signal: Calystegines are recognised as food and feed constituents with possible toxic effects, and comparative pathology in mice has examined calystegine A3 alongside the related glycosidase inhibitors swainsonine and castanospermine, with reported vacuolation of Kupffer cells. This places A3 within a toxicological rather than a nutritional frame. Claim strength: Emerging.

---

Dosage & Formulator Specification

Calystegine A3 is not a supplement ingredient and has no dosing. It is a naturally occurring constituent of common food plants — potato, tomato, eggplant, sweet potato — and it reaches the diet incidentally rather than by design. Herbuno does not offer it, and no botanical extract is standardised to it.

Its relevance to formulators is analytical and regulatory rather than commercial. Because calystegines survive cooking and processing, they are present in processed potato products, and cold storage measurably shifts the calystegine profile toward A3. Anyone working with Solanaceae-derived food ingredients may therefore encounter calystegines in a compositional analysis, and should recognise them as expected natural constituents rather than contaminants, while noting that they are classed as food and feed constituents with possible toxic effects.

The evidence also calls for a specific correction of a common overstatement. The calystegines as a group are frequently described as potent glycosidase inhibitors, and that generalisation has occasionally been used to suggest a blood-sugar application. The direct evidence for A3 does not support this: it showed low inhibition of human intestinal maltase and sucrase, and it was not transported across an intestinal cell model, indicating poor systemic availability. Neither finding supports a functional claim, and this monograph states that plainly rather than repeating the class-level generalisation.

This page documents calystegine A3 as an analytical and toxicological reference within the HerbIQ index, situating the nortropanes alongside the classical tropane alkaloids covered elsewhere, and is explicitly not a sourcing recommendation.

---

Frequently Asked Questions — Calystegine A3

What is calystegine A3?
Calystegine A3 is a polyhydroxylated nortropane alkaloid found in common food plants of the Solanaceae and Convolvulaceae, notably potato, tomato, eggplant, and sweet potato. Its sugar-mimicking structure allows it to interact with carbohydrate-processing enzymes.

Is calystegine A3 a strong glycosidase inhibitor?
Not particularly. Although the calystegines as a class are described as glycosidase inhibitors, calystegine A3 specifically showed low in vitro inhibition of human intestinal maltase and sucrase, whereas calystegine B2 inhibited sucrase activity more substantially. Neither compound was transported by Caco-2 cells, indicating low systemic availability.

Why is calystegine A3 informational-only?
It is a naturally occurring constituent of common foods rather than a commercial ingredient. No one standardises a botanical extract to calystegine A3; it is relevant to food analysis and toxicology rather than to formulation, so HerbIQ documents it as a reference compound.

Do calystegines survive cooking?
Yes. Calystegines are stable enough to survive cooking and are found in processed potato products. Cold storage of potatoes at around 5 degrees Celsius increases the proportion of calystegine A3, which is relevant to food analysis and to understanding dietary exposure.

Related compounds: Solanine, Chaconine, Atropine, Scopolamine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery